NCT04874454 Evaluating Potential Risk of Choking by Laryngeal Ultrasound in Patients With Acute Stroke
| NCT ID | NCT04874454 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Taiwan University Hospital |
| Condition | Acute Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2023-07-14 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2023-07-14 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators evaluate the vocal cord movement in patients with acute stroke by ultrasound. The occurrence of choking or aspiration pneumonia will be collected in one year after the index stroke.
Eligibility Criteria
Inclusion Criteria: * acute stroke (in one month) patients Exclusion Criteria: * patients with stroke occurring more than one month ago
Contact & Investigator
Wan-Ching Lien
PRINCIPAL INVESTIGATOR
National Taiwan University Hospital
Frequently Asked Questions
Who can join the NCT04874454 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, studying Acute Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04874454 currently recruiting?
Yes, NCT04874454 is actively recruiting participants. Contact the research team at wanchinglien@ntu.edu.tw for enrollment information.
Where is the NCT04874454 trial being conducted?
This trial is being conducted at Taipei, Taiwan.
Who is sponsoring the NCT04874454 clinical trial?
NCT04874454 is sponsored by National Taiwan University Hospital. The principal investigator is Wan-Ching Lien at National Taiwan University Hospital. The trial plans to enroll 200 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.